Based on a retrospective evaluation of patients with C3 ...
Artículos Científicos en Ingles
Artículos Científicos RSS AJKD
Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy | In Reply to ‘Benefit of Eculizumab Compared to Standard of Care Still Unproven in C3 Glomerulopathy’We agree with Duineveld et al1 that no definitive... | Kidney TattoosDan and Matt have a great deal in common, although they... |


